These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26427288)

  • 1. [Gram positive multi-drug resistance: what probability and fear?].
    Lina G; Cattoir V
    Bull Acad Natl Med; 2014 Mar; 198(3):427-38; discussion 438. PubMed ID: 26427288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Infection caused by glycopeptide resistant pathogens].
    Korn SJ; Stille W
    Internist (Berl); 2000 Dec; 41(12):1344-52. PubMed ID: 11189069
    [No Abstract]   [Full Text] [Related]  

  • 3. [Infections caused by multi-resistant Gram-positive bacteria (Staphylococcus aureus and Enterococcus spp.)].
    Cantón R; Ruiz-Garbajosa P
    Enferm Infecc Microbiol Clin; 2013 Oct; 31(8):543-51. PubMed ID: 24041416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infections caused by Gram-positive bacteria: a review of the global challenge.
    Woodford N; Livermore DM
    J Infect; 2009 Sep; 59 Suppl 1():S4-16. PubMed ID: 19766888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
    Napolitano LM
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New bisanthraquinone antibiotics and semi-synthetic derivatives with potent activity against clinical Staphylococcus aureus and Enterococcus faecium isolates.
    Socha AM; LaPlante KL; Rowley DC
    Bioorg Med Chem; 2006 Dec; 14(24):8446-54. PubMed ID: 16979896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains].
    Efe S; Sinirtaş M; Ozakin C
    Mikrobiyol Bul; 2009 Oct; 43(4):639-43. PubMed ID: 20084917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci.
    Leclercq R
    Clin Microbiol Infect; 2009 Mar; 15(3):224-31. PubMed ID: 19335370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Update of antimicrobial resistance in Gram-positive microorganisms].
    Cercenado E
    Med Clin (Barc); 2010 Dec; 135 Suppl 3():10-5. PubMed ID: 21477699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
    Dowzicky MJ
    Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Emergence of vancomycin-dependent enterococci following glycopeptide therapy: case report and review].
    Bert F; Leflon-Guibout V; Le Grand J; Bourdon N; Nicolas-Chanoine MH
    Pathol Biol (Paris); 2009 Feb; 57(1):56-60. PubMed ID: 18845404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistant gram-positive organisms.
    Schaberg DR
    Ann Emerg Med; 1994 Sep; 24(3):462-4. PubMed ID: 8080144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of antibiotic-resistant Gram-positive pathogens.
    Lode HM
    Clin Microbiol Infect; 2009 Mar; 15(3):212-7. PubMed ID: 19335368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin-resistant enterococcus (VRE) vs Methicillin-resistant Staphylococcus Aureus (MRSA).
    Ashwin KS; Muralidharan NP
    Indian J Med Microbiol; 2015 Feb; 33 Suppl():166-7. PubMed ID: 25657146
    [No Abstract]   [Full Text] [Related]  

  • 16. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.
    Nordmann P; Naas T; Fortineau N; Poirel L
    Curr Opin Microbiol; 2007 Oct; 10(5):436-40. PubMed ID: 17765004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
    J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Gram-positives in healthcare.
    Calfee DP
    Curr Opin Infect Dis; 2012 Aug; 25(4):385-94. PubMed ID: 22614523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
    Wang Z; Cao B; Liu YM; Gu L; Wang C
    Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms].
    Martínez-Gómez Dde A; Ramírez-Almagro C; Campillo-Soto A; Morales-Cuenca G; Pagán-Ortiz J; Aguayo-Albasini JL
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):317-21. PubMed ID: 19237227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.